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In order to survey a universe of major histocompati-
bility complex (MHC)-presented peptide antigens
whose numbers greatly exceed the diversity of the
T cell repertoire, T cell receptors (TCRs) are thought
to be cross-reactive. However, the nature and extent
of TCR cross-reactivity has not been conclusively
measured experimentally. We developed a sys-
tem to identify MHC-presented peptide ligands by
combining TCR selection of highly diverse yeast-dis-
played peptide-MHC libraries with deep sequencing.
Although we identified hundreds of peptides reactive
with each of five different mouse and human TCRs,
the selected peptides possessed TCR recogni-
tion motifs that bore a close resemblance to their
known antigens. This structural conservation of the
TCR interaction surface allowed us to exploit deep-
sequencing information to computationally identify
activating microbial and self-ligands for human
autoimmune TCRs. The mechanistic basis of TCR
cross-reactivity described here enables effective
surveillance of diverse self and foreign antigens
without necessitating degenerate recognition of
nonhomologous peptides.INTRODUCTION
T cells are central to many aspects of adaptive immunity. Each
mature ab T cell expresses a unique ab T cell receptor (TCR)
that has been selected for its ability to bind to peptides presented
by major histocompatibility complex (MHC) molecules. Unlike
antibodies, TCRs generally have low affinity for ligands (dissoci-
ation constant [KD] 1–100 mM), which has been speculated to
facilitate rapid scanning of peptide-MHC (pMHC) (Matsui et al.,
1991; Rudolph et al., 2006; Wu et al., 2002). Structural studies
of TCR-pMHC complexes have revealed a binding orientationwhere, generally, the TCR CDR1 and CDR2 loops make the ma-
jority of contacts with the tops of the MHC helices, whereas the
CDR3 loops, which are conformationally malleable, primarily
engage the peptide presented in the MHC groove (Davis and
Bjorkman, 1988; Garcia and Adams, 2005; Rudolph et al., 2006).
The low affinity and fast kinetics of TCR-pMHC binding, com-
bined with conformational plasticity in the CDR3 loops, would
seem to facilitate cross-reactivity with structurally distinct pep-
tides presented by MHC (Mazza et al., 2007; Reiser et al.,
2003; Yin and Mariuzza, 2009). Indeed, given that the calculated
diversity of potential peptide antigens is much larger than TCR
repertoire diversity, TCR cross-reactivity appears to be a biolog-
ical imperative (Mason, 1998; Sewell, 2012). Cross-reactive
TCRs have been implicated in both pathogenic and protective
roles for a number of diseases (Benoist and Mathis, 2001; De
la Herran-Arita et al., 2013; Shann et al., 2010; Welsh et al.,
2010; Wucherpfennig and Strominger, 1995).
Nevertheless, the true extent of TCR cross-reactivity, and its
role in T cell immunity, remains a speculative issue, largely due
to the absence of quantitative experimental approaches that
could definitively address this question (Mason, 1998; Morris
and Allen, 2012; Shih and Allen, 2004; Wilson et al., 2004;
Wucherpfennig et al., 2007). Although many examples exist of
TCRs recognizing substituted or homologous peptides related
to the antigen (Borbulevych et al., 2009, 2011; Krogsgaard
et al., 2003), such as altered peptide ligands (Kersh and Allen,
1996), most of these peptides retain similarities to the wild-
type (WT) peptides and are recognized in a highly similar fashion.
Only a handful of defined examples exist of a single TCR recog-
nizing nonhomologous sequences (Adams et al., 2011; Basu
et al., 2000; Colf et al., 2007; Ebert et al., 2009; Evavold et al.,
1995; Lo et al., 2009; Macdonald et al., 2009; Nanda et al.,
1995; Reiser et al., 2003; Zhao et al., 1999).
One approach that has been used to estimate cross-reactivity
utilizes pooled, chemically synthesized peptide libraries (Hem-
mer et al., 1998b; Wilson et al., 2004; Wooldridge et al., 2012).
Using calculations basedupon this technique, it hasbeenextrap-
olated that 106 different peptides in mixtures containing 1012
different peptides were agonists (Wilson et al., 2004; Wooldridge
et al., 2012). Synthetic peptide libraries have been used to isolateCell 157, 1073–1087, May 22, 2014 ª2014 Elsevier Inc. 1073
diverse peptide sequences (Hemmer et al., 1998a), including mi-
crobial andself-ligands for TCRsof interest (Hemmer et al., 1997).
However, most studies find only close homologs to known pep-
tides (Krogsgaard et al., 2003; Maynard et al., 2005; Wilson
et al., 1999, 2004). Furthermore, these cross-reactivity estimates
werederived from thebulk stimulatory ability of libraries possess-
ing femtomolar concentrations of any given peptide and no
knowledge of peptide loading in the MHC or pMHC binding to
the TCR. A more accurate estimate of cross-reactivity requires
the isolation of individual sequences from a library of MHC-pre-
sented peptides based upon binding to a TCR.
Recently, we and others have created libraries of peptides
linked to MHC via yeast and baculovirus display as a method
to discover TCR ligands through affinity-based selections that
rely on a physical interaction between the pMHC and the TCR
(Adams et al., 2011; Birnbaum et al., 2012; Crawford et al.,
2004, 2006; Macdonald et al., 2009; Wang et al., 2005). How-
ever, these methods have so far not been used to address the
broader question of TCR cross-reactivity, given that the require-
ment of manually validating and sequencing individual library
‘‘hits’’ has restricted the approach to discovering small numbers
of peptides.
Here, we combined affinity-based selections of pMHC yeast
libraries and deep sequencing to discover hundreds of unique
peptide sequences recognized by multiple murine and human
TCRs. Strikingly, all peptide sequences bear TCR epitopes
with close similarity to their previously known agonist antigens.
With an understanding of this property, we created a computa-
tional algorithm to predict naturally occurring TCR ligands using
data from our deep-sequencing results. We tested a diverse set
of the putative TCR-reactive peptides and found that 94% are
able to elicit a T cell response. In general, TCR cross-reactivity
does not appear to be characterized by broad degeneracy but
rather is largely constrained to a small number of TCR contact
residue ‘‘hot spots’’ on a peptide, while tolerating extensive di-
versity at other positions. This more granular understanding of
the properties of TCR cross-reactivity has broad implications
for ligand identification, vaccine design, and immunotherapy.
RESULTS
Development and Selection of a Murine MHC Platform
for Yeast Display
We developed a system for the rapid and sensitive detection of
TCR-binding peptides presented by the murine class II MHC
I-Ek. This represents an advance over previous reports of class
II pMHC molecules displayed on the surface of yeast that either
did not show or were not tested for the ability to bind soluble TCR
(Birnbaum et al., 2012; Boder et al., 2005; Esteban and Zhao,
2004; Jiang and Boder, 2010; Starwalt et al., 2003; Wen et al.,
2008, 2011). We designed our construct as a ‘‘mini’’ single-chain
MHC Aga2 fusion, with the truncated peptide-binding b1a1 do-
mains fused and theWT peptideMoth Cytochrome C (MCC, res-
idues 92–103) fused to the N terminus of the MHC b1 domain via
Gly-Ser linkers (Figure 1A) (Adams et al., 2011). The initial
construct was correctly routed to the yeast surface but did not
have the ability to bind to TCR, indicating that the pMHC was
not correctly folded (Figure 1B).1074 Cell 157, 1073–1087, May 22, 2014 ª2014 Elsevier Inc.In order to rescue folding of the pMHC, we subjected the mini
I-Ek to error-prone mutagenesis combined with introduction of
solubility-enhancing mutations. We selected this mutagenized
mini scaffold for binding to the 2B4 TCR, which recognizes
MCC-I-Ek with moderate affinity and slow kinetics (Newell
et al., 2011). Our final construct contained solubilizing mutations
in what was previously the a1b1-a2b2 domain interface and one
mutation between theMHChelix and the beta sheets (Figure 1B).
None of the mutated MHC residues contacted either the peptide
or the TCR. The evolved construct retained specific binding to
severalMCC-I-Ek-recognizing TCRsandshowedcomparable af-
finity to the WT pMHC (Figure 1B and Figure S1 available online).
We then created a peptide library tethered to the MHC
construct. Based upon the recently solved 2B4-MCC-I-Ek struc-
ture (Newell et al., 2011), wemutagenized the peptide fromP(2)
to P10 (Figure 1C). Limited diversity was introduced at the two
most distal residues and the primary MHC-binding anchor resi-
dues at P1 and P9 to maximize the number of peptides capable
of being correctly displayed by the MHC (Figure 1C).
Our first attempts at screening involved ‘‘manual curation’’ of
selections conducted with multivalent TCR. The library showed
enrichment after three rounds of selection using highly avid
TCR-coated streptavidin beads followed by a higher stringency
‘‘polishing’’ round of selection using TCR tetramers. The three
peptides that were recovered via sequencing of 12 individual,
hand-picked clones after selection were related to the WT
MCC peptide—the P2, P5, and P8 TCR contacts were all
conserved, whereas P3 showed a conservative Tyr-to-Phe mu-
tation (Figure 1D). We surmised that these enriched WT-like se-
quences present in the later rounds dominated the selections,
preventing alternative, potentially nonhomologous sequences
from being recovered. For this reason, we turned to deep
sequencing at each step of the selection process to recover all
enriched peptides.
Deep Sequencing of Selections for TCR-Binding
Peptides
Analysis of the pooled yeast library DNA after each successive
round of selection with 2B4 via deep sequencing showed enrich-
ment from an essentially random distribution of amino acids to a
highly WT-like TCR recognition motif (Figures 2A and S2A). After
the third round, there were nonhomologous amino acids at P5
and P8 selected above background (Met and Ser for P5, Ile
and Leu for P8) that were outcompeted by the WT-like motif by
the final round of selection. Overall, the number of unique pep-
tides observed via deep sequencing progressed from 132,000
unique in-frame peptides observed in the sequenced portion of
preselection library to only 207 unique peptides after the 3rd
round of selection (Figures 2B, 2C, S2A, and S2B). By the final
round of selection, the library was dominated by a handful of
sequences, matching the result obtained by manual curation
(Figures 1D, 2B, and 2C).
We repeated the selections with two other TCRs reactive to
MCC-I-Ek: 226 and 5cc7. We analyzed enrichment for each
TCR after the third round of selection, where there is enrichment
for a binding motif but before complete convergence to a small
number of sequences (Figures 2A, 3A, S2B, and S3A). Although
all three TCRs retain a WT-like TCR recognition motif (indicated
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Figure 1. Library Design and Selection of I-Ek, a Murine Class II MHC Molecule
(A) Schematic of the murine class II MHC I-Ek displayed on yeast, as b1a1 mini MHC with peptide covalently linked to MHC N terminus.
(B) Mutations required for correct folding of the b1a1 mini I-Ek (top). Mutations were derived from error-prone mutagenesis and selection (purple) and rational
design (red). Staining with 2B4 and 226 tetramers demonstrates function of error-prone-only construct (1st gen MHC) as well as error-prone + designed mutant
construct (2nd gen MHC) (bottom).
(C) Design of the peptide library displayed by I-Ek. Design is based upon the structure of 2B4 bound to MCC-I-Ek (left). Residues from P(2) to P10 are ran-
domized, with limited diversity at P(2), P10, and the P1/P9 anchors (right).
(D) 500 nM TCR tetramer staining of three clones selected for binding to 2B4 TCR compared to MCC (WT). TCR contact residues are colored red.
See also Figure S1.
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Figure 2. Deep Sequencing of Peptide Selections on I-Ek Converges on One Dominant Epitope for 2B4 TCR Recognition
(A) Plots for amino acid prevalence at the three primary TCR contact positions (P3 [cyan], P5 [magenta], and P8 [orange]) show that the peptide library enriches
from even representation of all amino acids in the preselection library to a WT-like motif at each position. A secondary preference can be seen at P5 and P8 in
round 3 but is outcompeted by round 4.
(B) Sequence enrichment of 250 most abundant peptides shows a convergence from a broad array of sequences to a few clones. Area in gray represents all
clones other than the most prevalent 250.
(C) Comparison of total number of peptides and prevalence of 10 most abundant peptides for each round of selection.
See also Figure S2.by the outlined boxes in the heatmaps), each TCR also shows
some variation in positional preferences (Figure 3A). For
example, where 2B4 can recognize P5 Met and Ser, 5cc7 can
accommodate P5 Leu, Val, and Arg. The P3 TCR contact posi-1076 Cell 157, 1073–1087, May 22, 2014 ª2014 Elsevier Inc.tion showed the least variance across all three TCRs, with either
Phe or Tyr being required for 2B4 and 5cc7, and Phe, Tyr, or Trp
being required for 226 (Figure 3A). 226, as previously reported,
showed a greater degree of cross-reactivity, able to recognize
AB
C
Figure 3. Three Different MCC/I-Ek-Reactive TCRs Require a WT-like Recognition Motif in the Peptide Antigens
(A) Heatmaps of amino acid preference by position for 2B4 (left, red) 5cc7 (center, green), and 226 (right, blue) TCRs after three rounds of selection. The sequence
for MCC is represented via outlined boxes. TCR contact residues are labeled red on the x axis.
(B) Covariation analysis of TCR contact positions P5 (x axis) and P8 (y axis) show distinct coupling of amino acid preferences.
(C) Minimum distance clustering of all TCR sequences selected above background shows that sequences for all TCRs form one large cluster with MCC (black
circle, not represented in library but added for reference). Sequence cluster is placed in a representation of whole-library sequence space (left: 13magnification,
center: 10003 magnification) for reference.
See also Figure S3.
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897 unique peptide sequences. The larger number of peptides
recognized was largely a function of a higher tolerance for
substitutions on TCR-neutral and MHC-contacting residues,
such as at positions P(1) and P4 (Figures 3A and S3A) (Ehrich
et al., 1993; Newell et al., 2011).
The large collection of peptides recovered via deep
sequencing enabled us to apply covariation analysis to discover
intrapeptide structure-activity relationships that were not previ-
ously accessible with traditional single-residue substitution anal-
ysis (Figure 3B) (Ehrich et al., 1993; Newell et al., 2011; Reay
et al., 1994; Wilson et al., 1999). By using covariation analysis
of the central P5 residue and the C-terminal P8 residue, a pattern
emerged: the native, MCC-like ‘‘up-facing’’ TCR-contact motifs
for each TCR (P5 Lys, P8 Ser/Thr) were strongly correlated,
whereas the altered residues (P5 Ser/P8Leu for 2B4, P5 Leu or
Arg/P8 Phe for 5cc7) independently segregated (Figure 3B).
These results highlight a degree of cooperativity in the composi-
tion of residues comprising a ‘‘TCR epitope’’ that is clearly re-
vealed with deep sequencing. Furthermore, such intrapeptide
residue coupling reveals how cross-reactivity can occur through
mutually compensatory substitutions to the parent peptide.
Although the selected ligands for all three TCRs possessed
shared features, each TCR also selected for a subset of se-
quences that were not selected by the other two.We applied dis-
tance clustering to the peptides selected by all three TCRs to
determine whether all selected sequences were part of the larger
MCC-like peptide family or were distinct families (Figure 3C).
We found that although sequences recognized by individual
TCRs clustered more closely to each other, essentially all of
the selected sequences formed one large cluster of peptides
no more than three amino acids different than at least one other
peptide in the cluster (Figures 3C and S3B). Therefore, the
selected peptides for all three TCRs are related via a common
specificity domain and, importantly, to the parent MCC ligand.
Even though we conducted unbiased selections of random li-
braries, the only ligands that were recovered were remarkably
similar to the WT ligand at the TCR interface.
Functional Characterization of I-Ek Library Hits
We synthesized 44 of the library peptides selected for binding
to the TCRs and examined their ability to stimulate T cell blasts
from 2B4 and 5cc7 transgenicmice as assayed by CD69 upregu-
lation and IL-2 production. Themajority of the peptides predicted
to bind 2B4 (19/19) and 5cc7 (17/21) expressing T cells induced
CD69 upregulation (Figures 4A, 4B, and S4A–S4D). The peptides
had a wide range of potencies, including 50-fold more potent
than the WT peptide MCC (colored red). When we compared
the presence of the MCC-like TCR recognition epitope with TCR
signaling, we found that in general, sequences that shared the
MCC-like epitope at all three major TCR contacts (colored blue)
were more potent in inducing signaling than those peptides that
were more distantly related (colored black) (Figures 4A and 4B).
We also tested the peptides selected for binding to one TCR for
their ability to cross-react with the other MCC-reactive T cells.
Surprisingly, a large proportion of these peptides potently acti-
vated TCR signaling (Figures 4A, 4B, and S4A–S4D). In general,
the sequences that showed themost robust activationwere again
the ones that most closely shared theMCCTCR-binding epitope.1078 Cell 157, 1073–1087, May 22, 2014 ª2014 Elsevier Inc.We additionally chose nine peptides from our initial set of 44
and exchanged them into soluble I-Ek MHC for TCR affinity mea-
surements via surface plasmon resonance (SPR). For 2B4 and
5cc7, TCR bound the pMHC of interest with affinities ranging
from KD of1 mM (over 10-fold better than that of MCC) to those
with binding only barely detectable at 100 mM TCR (Figures S4E
and S4F). When we compared the activity and affinity of our
selected peptides, there is a loose but positive correlation be-
tween strength of TCR-pMHC binding and potency of activation
(Figure 4C).
The Structural Basis of TCR Recognition of
Cross-Reactive Peptides
Todetermine themolecular basis of the TCRs’ ability to recognize
the most diverse peptides selected from our I-Ek libraries, we
determined the crystal structures of 2B4 in complex with a pep-
tide termed 2A bound to I-Ek as well as 5cc7 in complex with
two peptides bound to I-Ek, termed 5c1 and 5c2 (Table S1; Fig-
ures 5A and 5B). When these complexes were aligned with the
previously solved TCR-pMHC complex structures (2B4 and 226
binding MCC-I-Ek), very little deviation in overall TCR-pMHC
complex geometry was observed (Figures 5A and 5B) (Newell
et al., 2011). Because the 5cc7-MCC-I-Ek complex is not solved,
5c1 and 5c2 were compared to 226-MCC-I-Ek, which shares the
TCRb chain with 5cc7 and therefore likely retains a close foot-
print. The contacts between TCR germline-derived CDR1/2
loops and MHC helices, which make up roughly 50% of the
binding interface between TCR and pMHC, were essentially un-
changed in the new peptide complexes versus MCC (Figure 5C).
Whenwe examined the chemistry of MCC versus 2A andMCC
versus 5c1 peptide recognition by their respective TCRs, we saw
that the interactions between the TCRa CDR loops and the
N-terminal halves of the peptides are essentially invariant (Fig-
ures 5A and 5B, lower panels). Each peptide backbone makes
a hydrogen bond at the P3 carbonyl with Arg29a in the TCR
CDR1a loop (Figure S5A). The contacts of 2B4 CDR3a with P2
and P3 in MCC and 2A are essentially identical (Figure 5A, lower
panels). Although an exact analogy cannot be made between
5cc7 recognizing 5c1 and 226 recognizing MCC due to
sequence differences in their CDR3 loops, 5cc7 and 226
CDR3a loop conformations and peptide contacts are extremely
similar (Figure 5B, lower panels).
In contrast, 2B4 and 5cc7 b chain CDR loop interactions with
the C-terminal halves of the peptides show marked changes to
accommodate the non-MCC sequences. For 2B4, the CDR3b
loop conformation completely rearranges to engage the alter-
nate P5 and P8 residues on the 2A peptide (Figure 5A, lower
panels). Gln100b, a residue that makes no contact with the
peptide in the 2B4-MCC-I-Ek complex, flips its side chain by
180 degrees to form hydrogen bonds with the peptide backbone
carbonyl oxygens at P5 and P6 (Figure 5A, lower panels). The
side chains of Trp98b and Ser99b form hydrogen bonds with
the P5 Ser hydroxyl moiety (Figure 5A). Asp101b, one of the
main contacts with P5 Lys in MCC, forms a hydrogen bond
with Ser95b on the other end of the CDR3b loop, significantly
altering the overall topology of the loop (Figure S5B).
In the 5cc7-5c1-I-Ek complex, there are fewer hydrogen
bonds formed between the peptide and TCR due to the
5cc7 T cell activation
IL-
2 r
ele
as
e
CD
69
 up
reg
ula
tio
n
10-11
10-10
10-9
10-8
10-7
10-6
10-5
> 10-5
No Activity
EC
50
5cc7 T cell activation
IL-
2 r
ele
as
e
CD
69
 up
reg
ula
tio
n
10-11
10-10
10-9
10-8
10-7
10-6
10-5
 > 10-5
No Activity 
EC
50
2B4 T cell activation
IL-
2 r
ele
as
e
CD
69
 up
reg
ula
tio
n
10-11
10-10
10-9
10-8
10-7
10-6
10-5
 > 10-5
No Activity 
EC
50
2B4 T cell activation
IL-
2 r
ele
as
e
CD
69
 up
reg
ula
tio
n
10-11
10-10
10-9
10-8
10-7
10-6
10-5
 > 10-5
No Activity 
EC
50
A
B
2B4 T cell activation
MCC 3/3 MCC contacts homologous to MCC 0-2 contacts homologous to MCC
C
IL-2 release vs SPR KD
10-610-510-4
10-10
10-9
10-8
10-7
10-6
10-5
SPR KD
IL
-2
 E
C
50 5cc7
2B4
Selected by 2B4 Selected by 226/5cc7
5cc7 T cell activation
Selected by 5cc7 Selected by 226/2B4
MCC 3/3 MCC contacts homologous to MCC 0-2 contacts homologous to MCC
EC
50
EC
50
Figure 4. Relationships between Affinity and Activity of Peptides Selected for Binding to I-Ek-Reactive TCRs
(A) EC50s of IL-2 release and CD69 upregulation for 2B4 T cells stimulated with peptides selected with 2B4 TCR, plus MCC (red) (left), or peptides selected with
226 or 5cc7 TCRs (right). Sequences with close homology to MCC at P3, P5, and P8 are represented in blue. Sequences that do not share 3/3 TCR contacts with
MCC are in black.
(B) EC50s as in (A) for 5cc7 T cells with peptides selected with 5cc7 (left) or 226/2B4 (right) TCRs.
(C) Correlation between TCR-pMHC affinity and peptide signaling potency. Each data point represents one peptide.
See also Figure S4.replacement of P5 Lys with Leu in the 5c1 peptide (Figure 5B,
lower panels). Asn98b changes its hydrogen-bonding network
from engaging only the carbonyl of P6 on theMCCpeptide back-bone to simultaneously interacting with the carbonyl oxygen
of P6 and the amide nitrogen of P8 of the 5c1 peptide (Fig-
ure 5B). The second 5cc7-reactive peptide, 5c2, is recognizedCell 157, 1073–1087, May 22, 2014 ª2014 Elsevier Inc. 1079
Figure 5. Peptides Distantly Related to MCC Show Highly Similar Mechanism of Recognition and Linkages to the Cognate Antigen
(A andB) Comparison of crystal structures of TCR-pMHCcomplexes for 2B4-2A-I-Ek and 2B4-MCC-I-Ek (PDB ID: 3QIB) (A) and 5cc7-5c1-I-Ek and 226-MCC-I-Ek
(PDB ID: 3QIU) (B). TCR contacts are shown in magenta (top, noted with triangles). There is very little change in overall binding geometry despite significant
variation of peptide sequence. The TCRs accommodate differences in peptide sequence primarily through differences in CDR3b (bottom).
(C) TCR CDR loop footprints for 2B4 recognizing MCC and 2A peptides, 226 recognizing MCC and MCC K99E peptides, and 5cc7 recognizing 5c1 and 5c2
peptides show very little deviation.
(D) Relationship between MCC and 2A peptides revealed through intermediate selected peptide sequences.
See also Table S1 and Figure S5.
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essentially identically by 5cc7 as 5c1 despite the substitution of
P5 to Arg (Figure S5C). The substitution of a bulkier side chain at
P8 (Phe instead of Thr) results in a rocking of 5cc7 such that the
TCR Cb FG loop is translated by 15 A˚ relative to the 226-MCC
structure (Figures S5D and S5E). It is interesting to note that all
tested peptides with P8 Phe signal less efficiently than MCC-
like peptides, even when affinities are closely matched (Figures
S4E and S4F). These structures raise the question of whether a
minor tilt of the TCR relative to the MHC can have consequences
for signaling.
Upon closer inspection, we find that homologies between
what appear to be unrelated peptide sequences emerge from
sequence clustering and structural analysis. For example, close
structural relationships between the interaction modes of the
2B4-reactive peptides MCC and 2A are apparent even though
the peptides show little homology at 4/5 TCR contact positions
(Figure 5A). We set out to determine whether we could identify
intermediate sequences that would ‘‘evolutionarily’’ link these
two peptide sequences, given that both reside in the same
sequence cluster (Figure 3C). Using our data set of peptide se-
quences selected for 2B4 binding, we were able to populate a
family of peptides that would incrementally link MCC and 2A,
with each peptide differing by only one TCR contact from the
peptide before and after it (Figure 5D). Thus, connectivity can
be established between MCC and 2A through stepwise single
amino acid drifts from their parent sequences.
Collectively, despite differences in peptide sequences, all
MCC and library-peptide-derived complexes share many com-
mon features with regards to docking geometry and interaction
chemistry. Changes in up-facing peptide residue sequence
(e.g., P5, P8) are accommodated ‘‘locally’’ in a structurally parsi-
monious fashion that preserves most of the parent MCC peptide
complex features, as opposed to accommodation through large-
scale repositioning of the CDR loops on the pMHC surface.
Development and Selection of a Human MHC Platform
for Yeast Display
To exploit our technology to find ligands for TCRs relevant to hu-
mandisease, wealso engineered the humanMHCHLA-DR15, an
allele with genetic linkage tomultiple sclerosis (Hafler et al., 2007;
Patsopoulos et al., 2013). For yeast surface display, HLA-DR15
was constructed comparably to the murine I-Ek b1a1 mini MHC
(Figure 6A). We chose to examine two closely related TCRs,
Ob.1A12 and Ob.2F3, that were cloned from a patient with
relapsing-remitting multiple sclerosis and recognize HLA-DR15
bound to an immunodominant epitope of myelin basic protein
(MBP, residues 85–99) (Wucherpfennig et al., 1994b). These
two TCRs utilize the same Va-Ja and Vb-Jb gene segments
and differ at one position in the CDR3a loop and two positions
in CDR3b. Ob.1A12 is sufficient to cause disease in a humanized
TCR transgenic mousemodel (Harkiolaki et al., 2009; Hausmann
et al., 1999; Madsen et al., 1999). A structure of Ob.1A12
complexed with MBP-HLA-DR15 revealed an atypical docking
mode, with the TCR shifted toward the N terminus of the peptide
andprimarily interactingwith aP2-His/P3-Phe TCRcontactmotif
(Figure 6A) (Hahn et al., 2005; Wucherpfennig et al., 1994a).
Because the initial WT MBP-HLA-DR15 yeast display
construct was not stained by Ob.1A12 TCR tetramers, we sub-jected the construct to error-prone mutagenesis and selected
for binding with Ob.1A12. Our final construct combined the
most heavily selected mutation (Pro11Ser on HLA-DR15b) with
two solubility-enhancing mutations on the bottom of the MHC
platform (Figure S6A). The final construct stained robustly with
Ob.1A12 and Ob.2F3 TCR tetramers (Figure S6B).
We designed a peptide library within the HLA-DR15 mini MHC
scaffold to find novel Ob.1A12- and Ob.2F3-reactive peptides
(Figure 6A). Given that Ob.1A12 binds its cognate pMHC shifted
toward the N terminus of the peptide, we extended the library,
randomizing from P(4) to P10 (Hahn et al., 2005). The P1 and
P4 peptide anchors for HLA-DR15 were afforded limited diver-
sity. When we selected with Ob.1A12 and Ob.2F3 TCRs, we
observed a strong convergence to a WT MBP-like TCR recogni-
tion motif for the primary TCR contacts (P2 His, P3 Phe, and P5
Lys) (termed the ‘‘HF’’ motif) (Figures 6B, S6C, and S6D).
Given the dominance of the HF motif in the selection results,
we sought to determine whether alternative cross-reactive
TCR epitopes would emerge if the motif were suppressed. We
made a library that allowed every amino acid except for His at
P2, Phe at P3, and Lys at P5 (Figure 6C). After selection, the
TCR-binding clones still converged to a central HF motif by reg-
ister shifting toward the C terminus of the peptide by one amino
acid, allowing the previous P4 Phe anchor to be repurposed as
the P3 TCR contact and the P3 position of the library to become
the new P2 His TCR contact (Figure 6C). Furthermore, when we
subsequently prevented both His and Phe at P2 and P3 in a new
library to suppress potential register shifting, we did not isolate
any Ob.1A12- or Ob.2F3-binding peptides (data not shown).
These results show that the HF motif is required for TCR recog-
nition and its enrichment is a function of TCR preference, not any
inherent biases caused by the library or MHC anchor positions of
the peptide.
Clustering analysis of the selected peptides for both Ob.1A12
and Ob.2F3 showed distinct clusters consisting of peptides no
more than four amino acids different from each other (Figure 6D).
When the stringency of clustering is increased to allow no more
than three amino acid differences, matching the analysis done
for I-Ek, there were several more sparse clusters (Figure S6E).
Because Ob1.A12 and Ob.2F3 are so focused on the HF motif,
there are fewer total hot-spot residues distributed on the peptide
compared to the MCC-reactive TCRs we studied.
High-Confidence Prediction of Naturally Occurring
TCR-Reactive Peptides
The surprisingly limited degeneracy of TCR recognition suggests
that it may be feasible to identify naturally occurring TCR ligands
with a random peptide library. However, library selections and
deep sequencing alone are not sufficient to identify naturally
occurring ligands for two reasons. First, the size of yeast libraries
relative to all possible MHC-displayed peptides makes it unlikely
that any given peptide sequence exists in the library. Second, the
amino acid substitutions that are permitted at each position
along the peptide represent a complex, and as our covariation
analysis indicated, cooperative interplay between the peptide,
MHC, and TCR that may not be well described by common
substitution matrices such as BLOSUM (Henikoff and Henik-
off, 1992). For example, even though manual inspection ofCell 157, 1073–1087, May 22, 2014 ª2014 Elsevier Inc. 1081
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Figure 6. Design and Selection of HLA-DR15-Based Libraries for MBP-Reactive Human TCRs
(A) HLA-DR15 library design based upon structure of Ob.1A12-MBP-HLA-DR15 complex. Residues P(4)–P10 are fully randomized, except for the P1 and P4
anchors (in black). TCR contacts are colored magenta.
(B) Heatmap of amino acid preference by position for Ob.1A12 TCR. The sequence for MBP is represented via outlined boxes. TCR contacts are labeled red on
the x axis.
(C) Design and selection results of library that suppresses central HF TCR recognition motif at P2–P3 of peptide. Resulting register shift is shown in blue on x axis.
(D) Sequence clustering shows distinct, related clusters of selected peptides. Sequence cluster is placed in a representation of whole-library sequence space
(left: 13 magnification, center: 10003 magnification) for reference.
See also Figure S6.
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Ob.1A12-binding sequences readily shows theWT-like HFmotif,
the sequences do not find MBP as a match in blastp searches
(data not shown).
We therefore set out to develop an algorithm to use the
aggregate data from our selection results to inform searches
for candidate TCR antigens. First, we created a substitution ma-
trix that used the positional frequency information derived from
our Ob.1A12 and Ob.2F3 deep-sequencing data (Zhao et al.,
2001).Because the limited coverage of our libraries could lead
to appearance of residue biases at noncritical (i.e., neutral) pep-
tide positions that do not reflect actual selective pressure, we
created a new HLA-DR15-based library where we fixed the
dominant Ob.1A12-binding motif (P2 His, P3 Phe, and P5 Lys/
Arg) along with the P1 and P4 MHC-binding anchors, while
randomizing the remaining residues. When the selected libraries
were sequenced, we found that whereas some proximal posi-
tions such as P(1) and P(2) still showed distinct residue
preferences, other positions such as P7 and P8 showed less
convergence relative to the original HLA-DR15 library (Fig-
ure S7A). The more granular substitution data for peptide posi-
tions distal to the TCR-binding hot spot allowed us to construct
a more reliable algorithm.
We compiled two 14 3 20 substitution matrices consisting of
the observed frequencies of the 20 amino acids at each of the 14
positions of the library peptides from the focused DR15 pMHC
libraries selected by Ob.1A12 and Ob.2F3 (Figures 7A and
S7A; Table S2) (Zhao et al., 2001). Given that minimal residue
covariation was observed for Ob.1A12 and Ob.2F3 selections,
each position was treated independently (Figure S7B). Our pep-
tide database search using the Ob.1A12-based matrix yielded
2,330 unique hits, including MBP. For the search based on the
Ob.2F3 matrix, we had 4,824 unique hits, again including MBP.
The peptide hits shared the central P(1)-P5 motif of MBP, but
the flanking residues showed very little sequence homology
to either MBP or each other (Figure 7B; Table S3). The predicted
peptides are from diverse microbial sources, such as bacteria;
from environmental sources, such as antigens expressed by
plants; and from proteins in the human proteome.
To test our computationally predicted ligands for Ob.1A12 and
Ob.2F3, we synthesized a diverse set comprising 26 of the poten-
tial environmental antigensaswell as7novel humanpeptidespre-
dicted to cross-react with Ob.1A12 and Ob.2F3. When we tested
the 33 putative ligands for activity, 25/26 of the environmental
antigens and 6/7 of the human peptides induced proliferation for
Ob.1A12 and/or Ob.2F3, a success rate of 94% (Figure 7B).
DISCUSSION
The concept of TCR cross-reactivity is important because
key aspects of T cell biology, including thymic development,
pathogen surveillance, autoimmunity, and transplant rejection,
seemingly require recognition of diverse ligands. In this study,
we aimed to define the mechanisms underlying TCR speci-
ficity and cross-reactivity using a combinatorial, biochemical
approach that yielded massive data sets based on direct selec-
tion. This has given us insight into the structural basis of TCR
cross-reactivity and also provides a robust way to discover pep-
tide ligands for a TCR of interest.Our results clarify previous controversies on whether TCRs
are highly cross-reactive or highly specific by leveraging large
amounts of experimental data found via direct binding of
pMHC to TCR. We find that structural principles allow for the
TCR to engage large numbers of unique pMHCwithout requiring
degeneracy in pMHC recognition. If the criterion of cross-reac-
tivity is simply the number of unique peptide sequences that
can be recognized by any given TCR, then TCRs do exhibit a
high degree of cross-reactivity. Given that the libraries greatly
undersample all possible sequence combinations, it is likely
that our hundreds of discovered peptides are emblematic
of thousands of different peptides that can be recognized by
the studied TCRs. However, when cross-reactive peptides are
examined en masse, we find conserved TCR-binding (i.e.,
up-facing) motifs. TCR cross-reactivity is not achieved by each
receptor recognizing a large number of unrelated peptide
epitopes but rather through greater tolerance for substitutions
to peptide residues outside of the TCR interface, differences
in residues that contact the MHC, and relatively conservative
changes to the residues that contact the TCR CDR loops. The
segregation of TCR recognition and MHC binding allows for
TCRs to simultaneously accommodate needs for specificity
and cross-reactivity.
Although we believe this mechanism will be general for ab
TCRs, recognition of nonhomologous antigens certainly occurs
to varying degrees in the TCR repertoire, although molecularly
defined examples are surprisingly rare. The ability for one TCR
to bind to multiple MHCs (e.g., alloreactivity), for one TCR to
bind in multiple orientations on oneMHC, for a peptide to nonca-
nonically bind MHC (e.g., partially filled MHC grooves, register-
shifted peptides), or for a TCR to have TCR-peptide contacts
as a disproportionately large or small part of the overall interface
(e.g., ‘‘super-bulged’’ peptides) will grant some receptors a
greater degree of epitope promiscuity (Adams et al., 2011; Colf
et al., 2007; Maynard et al., 2005; Morris and Allen, 2012; Morris
et al., 2011; Tynan et al., 2005). It is also possible that class I
versus class II MHC-specific TCRs could exhibit different de-
grees of cross-reactivity as a consequence of the ‘‘low-lying’’
peptides in the class II groove, versus the elevated or ‘‘higher-
profile’’ peptides presented by class I. Indeed, in a prior study,
multiple peptides reactive with a class I-specific (H-2Ld) murine
TCR were identified through manual curation, and the structures
indicated a diverse recognition chemistry by the TCR CDR3
loops (Adams et al., 2011). In retrospect, a close inspection
reveals striking commonalities in the peptide-binding chemistry
by the TCR, in particular a requirement for a hydrophobic con-
tact at the apex of the P7 ‘‘bulge’’ that forms the principal site
of contact with the TCR CDR3b. In contrast, a second class I
TCR, 2C, was not found to exhibit peptide degeneracy, instead
exhibiting specificity for its endogenous antigen, QL9, in a
manner similar to that of the class II-specific TCRs studied
here (unpublished data).
An important implication of our findings, which is consistent
with previous studies (Macdonald et al., 2009), is that identifica-
tion of endogenous antigens of TCRs is feasible using pMHC
libraries. In our previous view of cross-reactivity, we assumed
that a given TCR would cross-react with so many peptides in a
library that elucidation of ‘‘natural’’ leads from a background ofCell 157, 1073–1087, May 22, 2014 ª2014 Elsevier Inc. 1083
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Figure 7. Discovery of Naturally Occurring TCR Ligands through Deep Sequencing and Substitution-Matrix-Based Homology Search
(A) Schematic for ligand search strategy, in which a positional substitution matrix is generated from deep-sequencing data and then used to find naturally
occurring peptides that are represented within the matrix.
(B) Functional characterization of a selection of naturally occurring peptides with predicted activity. Activity is tested via proliferation of T cells when exposed to
peptide. Heatmaps are normalized to 10 mM dose of MBP peptide for each T cell clone.
See also Tables S2 and S3 and Figure S7.degenerately binding sequences would be extremely difficult.
Additionally, the sparse coverage of possible sequences renders
it unlikely that any given sequence of interest will be represented1084 Cell 157, 1073–1087, May 22, 2014 ª2014 Elsevier Inc.with 100% identity in our library. However, limited TCR epitope
cross-reactivity allows us to use selection results to constrain
computational searches of protein databases, which proves to
be a highly successful strategy for finding naturally occurring
TCR ligands. Thus, this approach now opens up the possibility
of peptide ligand discovery for ‘‘orphan’’ TCRs such as those
from regulatory T cells and tumor-infiltrating lymphocytes (TILs).
Although the naturally occurring peptides in this study were
found as a proof of principle for our methodology, they further
support the hypothesis that autoimmune T cells have the ability
to be activated by immunogens encountered in the environment,
which may serve as the trigger for the initiation of autoimmunity
(De la Herran-Arita et al., 2013; Harkiolaki et al., 2009; Hausmann
et al., 1999; Wucherpfennig and Strominger, 1995). Additionally,
the potential for other human peptides to cross-react with auto-
immune TCRs with previously ‘‘known’’ antigens presents the
intriguing possibility that individual TCRs can recognize multiple
self-peptides, potentially contributing to T cell pathologies in
autoimmune disease. This notion is supported by the finding
that a murine TCR specific for myelin-oligodendrocyte glycopro-
tein cross-reacts with a second CNS antigen, neurofilament M.
Due to this unexpected cross-reactivity, these T cells remained
pathogenic even in MOG-deficient mice (Krishnamoorthy et al.,
2009). Our approach for systematic discovery of peptides recog-
nized by human TCRs thus has the potential to advance our
understanding of complex pathogenesis of immune-mediated
diseases.
EXPERIMENTAL PROCEDURES
Creation and Selection of pMHC Libraries
Peptide libraries were created through use of mutagenic primers allowing all
20 amino acids via NNK codons. The libraries allowed limited diversity at
the known MHC anchor residues to maximize the number of correctly folded
and displayed pMHC clones in the library. Yeast libraries were created by
electroporation of competent EBY-100 cells via homologous recombination
of linearized pYAL vector and mutagenized pMHC construct essentially as
described previously (Adams et al., 2011; Chao et al., 2006). Final libraries con-
tained approximately 2 3 108 yeast transformants.
Yeast libraries were selected for binding to the TCR of interest coupled to
streptavidin-coated magnetic beads (Miltenyi) through magnetic-activated
cell sorting. After libraries enriched above the baseline of streptavidin beads
alone (typically after three rounds of selection), a final round of selection was
conducted with fluorescently labeled streptavidin tetramers.
Deep Sequencing of pMHC Libraries
Pooled plasmids from 5 3 107 yeast from each round of selection were
isolated via yeast miniprep (Zymoprep II kit, Zymo Research) and used as
PCR template to prepare sequencing samples. The adaptor and barcode se-
quences were appended via nested 25-round cycles of PCR of the purified
plasmids using Phusion polymerase (NEB). Deep sequencing was conducted
on an Illumina MiSeq sequencer at the Stanford Stem Cell Institute Genome
Center.
Profile-Based Searches for Naturally Occurring Peptide Ligands
The positional frequencies from round 3 of the fixed HF library were used to
generate a 143 20 substitution matrix. Each protein in the NR (NCBI) or human
protein (Uniprot) databases was scanned using a 14 position sliding window
and scored as a product of the positional substitution matrix (Cockcroft and
Osguthorpe, 1991). In this way, a candidate peptide containing even a single
disallowed substitution would be excluded as a possible hit.
Structural Determination of pMHC-TCR Complexes
All crystallographic data were collected at the Stanford Synchroton Radiation
Lightsource (Stanford, CA, USA) beamlines 11-1 and 12-2. Data were indexed,
integrated, and scaled using either the XDS or the HKL-2000 program suites(Kabsch, 2010; Otwinowski et al., 1997). All structures were solved via molec-
ular replacement using the program Phaser (McCoy, 2007) and refined with
Phenix (Adams et al., 2010).
Extended Experimental Procedures
Further details for the design, selection, and sequencing of yeast display
libraries; methods for production, characterization, and crystallization of pro-
teins; and computational discovery and functional validation of peptide hits
can be found online in the Extended Experimental Procedures.
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